AL

Accel London III Associates L.P.

Long-term holder

Total reported value

—

Reporting period: 2022-09-30 · Number of holdings: 1

Accel London III Associates L.P. disclosed 1 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity
—

Recent moves

  • Unchanged 000000000

    　$0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1✓ Ikena Oncology INCStock-Other———

Holding changes this quarter

Position changes disclosed by Accel London III Associates L.P. for the quarter ending 2022-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1✓ Ikena Oncology INC——Unchanged

FAQ

What is Accel London III Associates L.P. and what type of investor is it?
Accel London III Associates L.P. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2022-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Accel London III Associates L.P.'s largest equity positions?
Based on the latest 13F filing, Accel London III Associates L.P.'s top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did Accel London III Associates L.P. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Accel London III Associates L.P. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Accel London III Associates L.P. focus on?
Sector breakdown data is not yet available for Accel London III Associates L.P.. Check back after the next 13F processing cycle.